SCHEMBL13637287

SCHEMBL13637287

O=C(O)Cc1ccc(OCC2(COc3ccc(-c4cccs4)cc3-n3nc4ccccc4n3)CCCC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
MAPT P10636 4/20 0.39
FFAR1 O14842 1/20 0.38
KDM4E B2RXH2 8/20 0.36
HPGD P15428 5/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
POLB P06746 2/20 0.36
RXFP1 Q9HBX9 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CYSLTR2 Q9NS75 1/20 0.34
CYSLTR1 Q9Y271 1/20 0.34
PPARG P37231 2/20 0.33
PPARA Q07869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13637284 0.97 FFAR1 (0.39) ALDH1A1MAPTFFAR1KDM4EHPGD
SCHEMBL3581379 0.86 FFAR1 (0.42) ALDH1A1MAPTFFAR1KDM4EHPGD
SCHEMBL13637283 0.82 KDM4E (0.41) ALDH1A1MAPTFFAR1KDM4EHPGD
SCHEMBL13407854 0.78 KDM4E (0.46) ALDH1A1MAPTFFAR1KDM4EHPGD
SCHEMBL13637288 0.77 KDM4E (0.44) ALDH1A1MAPTFFAR1KDM4EHPGD
SCHEMBL13637290 0.76 ALDH1A1 (0.40) ALDH1A1MAPTFFAR1HDAC1
SCHEMBL3589424 0.74 KDM4E (0.42) ALDH1A1MAPTFFAR1KDM4EHPGD
SCHEMBL13442138 0.74 PPARD (0.36) ALDH1A1MAPTFFAR1KDM4EHPGD
SCHEMBL13442153 0.74 KDM4E (0.36) ALDH1A1MAPTFFAR1KDM4EHPGD
SCHEMBL3587335 0.69 KDM4E (0.46) ALDH1A1MAPTFFAR1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622491-B2 Type 2 diabetes, atherosclerosis, cardiovascular disease, Syndrome X; carboxylic acids with dialkyldiether or thioether linking groups e.g. {4-[3-(2-Benzotriazol-2-yl-4-chloro-phenoxy)-propoxy]-phenyl}-acetic acid and {4-[3-(2-benzotriazol-2-yl-4-thiophen-2-yl-phenoxy)-propoxy]-phenyl}-acetic acid METABOLEX INC. (US) 2009-11-24 US disclosed